GSK plc (formerly GlaxoSmithKline, rebranded May 2022) is a UK-headquartered global biopharma dual-listed on the London Stock Exchange and NYSE under the ticker GSK. Following the July 2022 spin-off of its consumer-health business as Haleon, GSK is a focused biopharma operating across four therapeutic areas — infectious diseases, HIV, oncology, and respiratory/immunology/inflammation — with flagship vaccine franchises including Shingrix and Arexvy and the HIV joint venture ViiV Healthcare (held with Pfizer and Shionogi). GSK does not publish a public developer portal or commercial REST APIs.
URL: https://www.gsk.com
Run: Capabilities Using Naftiko
- Pharmaceutical, Biotechnology, Vaccines, HIV, Oncology, Healthcare, ClinicalTrials
No public developer APIs are published. Machine-readable surfaces and developer-facing assets are documented in apis.yml under common[]:
- GSK Study Register (7,400+ protocol summaries; 6,500+ results summaries) — search-only
- ClinicalStudyDataRequest.com (CSDR) — 13-sponsor consortium for patient-level clinical data sharing
- ClinicalTrials.gov registration (third-party API surface)
- ViiV Healthcare Study Register
- Press, Behind the Science podcast, RNS and SEC RSS feeds
- GSK-Biostatistics GitHub organization (29 public repos of R/Python clinical reporting and CDISC-on-Neo4j tooling)
- gskpro.com healthcare professional portal and supplier.gsk.com supplier portal
- X12 EDI for distributor integration; ICH E2B(R3) for pharmacovigilance
- Created: 2026-05-23
- Modified: 2026-05-23